Related Experiment Videos
[Colorectal cancer and folate].
Zeitschrift Fur Gastroenterologie
|March 29, 2003
Summary
High dietary folate intake, crucial for DNA methylation, is linked to a reduced risk of colorectal cancer. Low folate levels may increase cancer risk, especially with certain gene variations.
Area of Science:
- Nutritional Science
- Cancer Prevention
- Molecular Biology
Background:
- Nutritional factors significantly impact colorectal cancer (CRC) risk.
- Folate plays a vital role in DNA synthesis, methylation, and repair.
- Low folate status is hypothesized to increase CRC risk through altered gene expression and DNA damage.
Purpose of the Study:
- To review the evidence linking dietary folate intake to colorectal cancer risk.
- To explore the molecular mechanisms by which folate influences CRC development.
- To assess the impact of folate and other methyl donors on CRC risk.
Main Methods:
- Systematic review of epidemiological studies (retrospective and prospective).
- Analysis of genetic polymorphism data (methylenetetrahydrofolate reductase gene).
- Examination of intervention trial data on high folate intake and biomarkers.
Main Results:
- Consistent epidemiological evidence shows a high folate intake correlates with lower CRC risk.
- A specific MTHFR gene polymorphism increases CRC risk in individuals with low folate status.
- Diets low in methyl donors (folate, methionine) combined with high alcohol intake may elevate CRC risk.
Conclusions:
- Dietary folate is a significant protective factor against colorectal cancer.
- Maintaining adequate folate status is crucial for preventing DNA damage and regulating gene expression relevant to CRC.
- Further intervention trials are needed to confirm the effects of high folate intake on CRC biomarkers.